Adenocarcinome du duodenum. Contribution a l'etude d'une pathologie rare [Adenocarcinoma of the duodenum. Contribution to the study of a rare pathology]

Details

Serval ID
serval:BIB_9B88A506AA7D
Type
Article: article from journal or magazin.
Publication sub-type
Case report (case report): feedback on an observation with a short commentary.
Collection
Publications
Institution
Title
Adenocarcinome du duodenum. Contribution a l'etude d'une pathologie rare [Adenocarcinoma of the duodenum. Contribution to the study of a rare pathology]
Journal
Helv. Chir Acta
Author(s)
Vuilleumier  H., Cuttat  J. F., Blum  A. L., Chapuis  G.
ISSN
0018-0181 (Print)
Publication state
Published
Issued date
1994
Volume
60
Number
4
Pages
557-567
Notes
DA - 19940816
LA - fre
PT - Case Reports
PT - English Abstract
PT - Journal Article
Titre original : Adenocarcinome du duodenum. Contribution a l'etude d'une pathologie rare
SB - IM
Abstract
Primary adenocarcinoma of the duodenum is a rare lesion and represents 0.35% of all tumors of the gastrointestinal tract. 75% of the primary tumors of the duodenum are adenocarcinomas and 33-45% of the adenocarcinomas of the small bowel arise in the duodenum. The incidence of these tumors has been estimated to be 0.03%. The diagnosis is usually made at a very late stage because the symptoms are often non-specific. The mean diagnostic delay between beginning of symptoms and the diagnosis is of 10 months. Oesogastroduodenoscopy is the diagnostic procedure of choice and upper GI series is still of interest since it permits a topographic analysis of the lesion. Pancreatico-duodenectomy is recognized by a majority of authors as the standard curative procedure, in the absence of regional nodes. Survival after pancreaticoduodenectomy in the absence of local lymph node invasion is 68% at 5 years whereas there is no survivor after 3 years when there is regional invasion of the lymph nodes. Survival rates after palliative excisions are generally of 15 months, after bilio-digestive derivation of 6 months. Radical excision is preferable in as much as it is technically feasible
Keywords
Adenocarcinoma/mortality/pathology/surgery/Adult/Aged/Aged,80 and over/Duodenal Neoplasms/Duodenum/Female/Follow-Up Studies/Humans/Lymphatic Metastasis/Male/Middle Aged/Neoplasm Staging/Pancreaticoduodenectomy/Survival Rate
Pubmed
Web of science
Create date
18/02/2008 14:08
Last modification date
20/08/2019 16:02
Usage data